Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$338,528
-$72,829 QoQ
Shares Held
6,458
-32.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#566
of 1,033 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $6,932,010 across 7 Drug Manufacturers - General names. GSK ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,888 | $2,003,315 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
15,448 | $1,951,700 | |
| 3 | PFE |
Pfizer Inc
|
59,596 | $1,435,071 | |
| 4 | LLY |
ELI LILLY & Co
|
467 | $560,133 | |
| 5 | NVS |
Novartis AG
|
3,062 | $479,876 | |
| 6 | GSK |
GSK plc
This page
|
6,458 | $338,528 | |
| 7 | OGN |
Organon & Co.
|
12,067 | $163,387 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,528 | 6,458 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $411,357 | 9,531 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $353,740 | 9,212 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $459,378 | 11,858 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $563,610 | 16,665 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $393,592 | 9,628 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $231,032 | 6,234 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $484,404 | 13,785 | Shares | Sole | 2023-02-15 | |
| 2021-06-30 | $484,678 | 12,410 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||